title: Somatization, co-morbidity, and the quality of life: measuring the effect of depression upon chronic medical illness.
authors.affiliation: University of Washington Medical School, Seattle.
authors.forename: M
authors.initials: M
authors.lastname: Sullivan
authors.forename: W J
authors.initials: WJ
authors.lastname: Katon
authors.forename: J
authors.initials: J
authors.lastname: Russo
authors.forename: R
authors.initials: R
authors.lastname: Dobie
authors.forename: C
authors.initials: C
authors.lastname: Sakai
mesh_terms: D000203:Activities of Daily Living / Q000523:psychology; D001301:Audiometry, Pure-Tone; D002908:Chronic Disease; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology*; D004311:Double-Blind Method; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D009661:Nortriptyline / Q000627:therapeutic use; D010552:Personality Assessment; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life; D012803:Sick Role; D013001:Somatoform Disorders / Q000188:drug therapy / Q000523:psychology*; D014012:Tinnitus / Q000188:drug therapy / Q000523:psychology*
chemical_list: D009661:Nortriptyline